OPOCRIN
Live / Registered — Registered — Section 71 accepted (as of 10 Oct 2024)
What this means for you
Registered since 28 Aug 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79226268
- Registration number
- 5548005
- Mark type
- Design + words
- Filed
- 18 Dec 2017
- Published for opposition
- 12 Jun 2018
- Registered
- 28 Aug 2018
- Attorney of record
- ROBERT S. BRODER
Goods and services
- Class 001 — Chemicals: Chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical or medical purposes, namely, for treating Respiratory Distress Syndrome (RDS) in premature infants, for preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia; enzymes for medical purposes
Owner
- OPOCRIN S.p.A., Corlo di Formigine (MO), IT
- OPOCRIN S.p.A., IT
- OPOCRIN S.p.A., IT
Prosecution history
- 10 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 10 Oct 2024 — REGISTERED-SEC.71 ACCEPTED
- 07 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Feb 2024 — TEAS SECTION 71 RECEIVED
- 27 May 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 May 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Apr 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 27 Oct 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 17 Jul 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Dec 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 08 Dec 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 08 Dec 2018 — FINAL DISPOSITION PROCESSED
- 28 Nov 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 Aug 2018 — REGISTERED-PRINCIPAL REGISTER
- 12 Jun 2018 — PUBLISHED FOR OPPOSITION